RGS16 and neuroblastoma: Our data suggest that RA-induced changes in the expression of RARβ2, CYP26A1, CRBP1, RGS16, DUSP6, and EGR1 may be necessary for the retinoid anticancer signal in neuroblastoma, breast and/or lung cancer cells.